Ginkgo Bioworks' food-focused spinout raises $226M to get products on the table
Since its founding in early 2019, Motif FoodWorks has been tinkering with ways to engineer plant-based foods so they more closely mirror traditional animal-based ones: tweaking texture to mimic the pull of melted cheese, beefing up the nutrients in plant-based milk so it's as nutritional as cow's milk. Now, armed with an eye-popping $226 million in new funding, Motif is ready to get its products on the dinner table. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 16, 2021 Category: Health Management Authors: Rowan Walrath Source Type: news

What's in a ticker? Genentech's old 'DNA' stock symbol snagged by upstart Ginkgo
Ginkgo CEO Jason Kelly reportedly said the "DNA" ticker symbol that once belonged to Genentech was offered by the New York Stock Exchange to get Ginkgo to list there rather than NASDAQ. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 17, 2021 Category: Health Management Authors: Ron Leuty Source Type: news

What's in a ticker? Genentech's old 'DNA' stock symbol snagged by upstart Ginkgo
Ginkgo CEO Jason Kelly reportedly said the "DNA" ticker symbol that once belonged to Genentech was offered by the New York Stock Exchange to get Ginkgo to list there rather than NASDAQ. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Ginkgo Bioworks: start-up scores highly engineered valuation
The biotech’s business is costly but Spac transaction solves its cash burn problem (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 12, 2021 Category: Pharmaceuticals Source Type: news

Ginkgo Bioworks to go public in $17.5B SPAC deal
Ginkgo Bioworks bills itself as "the organism company," making custom microbes by programming cellular DNA. As a public firm, Ginkgo plans to continue that work, with ambitious plans to expand into "every physical goods company." (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 11, 2021 Category: American Health Authors: Rowan Walrath Source Type: news

Ginkgo Bioworks reportedly explores $20B SPAC deal
Synthetic biology company Ginkgo Bioworks is toying with the idea of going public via a reverse merger with special-purpose acquisition company Soaring Eagle Acquisition Corp. The potential deal, first reported by Bloomberg, could value Ginkgo at more than $20 billion — more than five times what Ginkgo was valued at in late 2019, when it last raised venture capital. Ginkgo Bioworks declined to comment. The news comes as deals with special-purpose acquisition compani es, known as the number of… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 12, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

Ginkgo Bioworks expands to former Au Bon Pain HQ in Boston ’s Seaport
The future eight-story lab is planned a stone ’s throw from Ginkgo Bioworks’ current home in Boston’s Seaport District. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 2, 2021 Category: Biotechnology Authors: Catherine Carlock Source Type: news

The Petri Dish: Ginkgo launches K-12 Covid tests, Catabasis acquires local startup
While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more. Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of Greater Boston life sciences and health care happenings. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

Whales alive: beaked species spotted for first time by Chinese scientists. Three whales seen in South China Sea were Deraniyagala ’s...
Three whales seen in the South China Sea were Deraniyagala or ginkgo-toothed species, researchers reveal. Both have previously been seen... (Source: Reuters: Health)
Source: Reuters: Health - December 31, 2020 Category: Consumer Health News Source Type: news

Looking to boost your libido and heart health? Evidence suggests taking ginkgo biloba
BEST supplements for men: Heart health and libido can be threatened by the ageing process. Fortunately, taking ginkgo biloba has been shown to protect both. (Source: Daily Express - Health)
Source: Daily Express - Health - November 20, 2020 Category: Consumer Health News Source Type: news

Epileptic seizure from ginkgo nut intoxication in an adult - Kosaki Y, Naito H, Nojima T, Nakao A.
The ginkgo tree is a well-known, highly adaptable urban plant. Ginkgo nuts are the product of the ginkgo tree. Interior ginkgo nuts are cooked and served in Asian countries; however, the potential toxicity of the gingko nuts is not commonly known. Herein, ... (Source: SafetyLit)
Source: SafetyLit - August 13, 2020 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

Coronavirus US: NIH gives $250m to seven firms making tests
The NIH said innovative tests by Mesa Biotech, Quidel, Ginkgo Bioworks, Talis Biomedical, Helix OpCo, Fluidigm and Mammoth Biosciences will help expand and speed testing in the US. (Source: the Mail online | Health)
Source: the Mail online | Health - August 1, 2020 Category: Consumer Health News Source Type: news

NIH awards nearly $250 million to seven firms making COVID tests
The NIH said innovative tests by Mesa Biotech, Quidel, Ginkgo Bioworks, Talis Biomedical, Helix OpCo, Fluidigm and Mammoth Biosciences will help expand and speed testing in the US. (Source: the Mail online | Health)
Source: the Mail online | Health - July 31, 2020 Category: Consumer Health News Source Type: news

The Government ’s ‘Shark Tank’-Style Coronavirus Testing Challenge Awards $250M To 7 Companies
The National Institutes of Health negotiated contracts with companies including Mammoth Biosciences and Ginkgo Bioworks to help scale up their Covid-19 testing technologies. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 31, 2020 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Business /business Policy /policy Editors' Pick editors-pick Coronavirus Source Type: news

Jurassic fossils from northeastern China reveal morphological stasis in the catkin-yew
(Science China Press) Dong and colleagues studied well-preserved plant fossils from the Middle-Late Jurassic Daohugou Bed in eastern Inner Mongolia, northeastern China. These fossils closely resemble the extant catkin-yews Amentotaxus. They provide unequivocal evidence that the catkin-yews have undergone little morphological change over at least ~160 million years. Like ginkgo, the catkin-yews are living fossils that provide an important new example of evolutionary stasis. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 11, 2020 Category: Biology Source Type: news